Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 1
1990 2
1991 2
1992 3
1993 3
1994 1
1995 3
1996 2
1997 1
1998 6
1999 3
2000 2
2002 1
2003 1
2004 1
2005 1
2006 7
2007 1
2008 6
2009 6
2010 5
2011 4
2012 13
2013 8
2014 6
2015 14
2016 26
2017 27
2018 32
2019 30
2020 30
2021 36
2022 25
2023 27
2024 29
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Vestibular Schwannomas.
Carlson ML, Link MJ. Carlson ML, et al. N Engl J Med. 2021 Apr 8;384(14):1335-1348. doi: 10.1056/NEJMra2020394. N Engl J Med. 2021. PMID: 33826821 Review. No abstract available.
Intralabyrinthine schwannomas.
Frisch CD, Eckel LJ, Lane JI, Neff BA. Frisch CD, et al. Otolaryngol Clin North Am. 2015 Jun;48(3):423-41. doi: 10.1016/j.otc.2015.02.004. Epub 2015 Apr 9. Otolaryngol Clin North Am. 2015. PMID: 25863567 Review.
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.
Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Piotrowski A, et al. Nat Genet. 2014 Feb;46(2):182-7. doi: 10.1038/ng.2855. Epub 2013 Dec 22. Nat Genet. 2014. PMID: 24362817 Free PMC article.
We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one copy of 22q, encompassing SMARCB1 and NF2, with a different somatic mutation of the other NF2 allele in every schwannoma but no mutati …
We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one c …
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Vestibular Schwannomas. Reply.
Carlson ML, Link MJ. Carlson ML, et al. N Engl J Med. 2021 Jul 22;385(4):381-382. doi: 10.1056/NEJMc2108279. N Engl J Med. 2021. PMID: 34289290 No abstract available.
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.
Plotkin SR, Yohay KH, Nghiemphu PL, Dinh CT, Babovic-Vuksanovic D, Merker VL, Bakker A, Fell G, Trippa L, Blakeley JO; INTUITT-NF2 Consortium. Plotkin SR, et al. N Engl J Med. 2024 Jun 27;390(24):2284-2294. doi: 10.1056/NEJMoa2400985. Epub 2024 Jun 21. N Engl J Med. 2024. PMID: 38904277 Clinical Trial.
On the basis of preclinical activity of brigatinib (an inhibitor of multiple tyrosine kinases) in NF2-driven nonvestibular schwannoma and meningioma, data were needed on the use of brigatinib in patients with multiple types of progressive NF2-SWN tumors. ...RESULTS: A tota …
On the basis of preclinical activity of brigatinib (an inhibitor of multiple tyrosine kinases) in NF2-driven nonvestibular schwannoma
Lipochoristoma of the Cerebellopontine Angle.
Ellis TW, Goates AJ, Eschbacher KL, Giannini C, Lane JI, Van Gompel JJ, Carlson ML. Ellis TW, et al. Otol Neurotol. 2022 Mar 1;43(3):e394-e396. doi: 10.1097/MAO.0000000000003412. Otol Neurotol. 2022. PMID: 34772883 No abstract available.
Beyond Tympanomastoidectomy: A Review of Less Common Postoperative Temporal Bone CT Findings.
Panda A, Carlson ML, Diehn FE, Lane JI. Panda A, et al. AJNR Am J Neuroradiol. 2021 Jan;42(1):12-21. doi: 10.3174/ajnr.A6802. Epub 2020 Nov 12. AJNR Am J Neuroradiol. 2021. PMID: 33184072 Free PMC article. Review.
Postoperative temporal bone imaging after surgical procedures such as ossiculoplasty, tympanomastoidectomy, cochlear implantation, and vestibular schwannoma resection is often encountered in clinical neuroradiology practice. ...
Postoperative temporal bone imaging after surgical procedures such as ossiculoplasty, tympanomastoidectomy, cochlear implantation, and ve
Introducing an Evidence-Based Approach to Wait-And-Scan Management of Sporadic Vestibular Schwannoma: Size Threshold Surveillance.
Marinelli JP, Lohse CM, Carlson ML. Marinelli JP, et al. Otolaryngol Clin North Am. 2023 Jun;56(3):445-457. doi: 10.1016/j.otc.2023.02.006. Epub 2023 Apr 3. Otolaryngol Clin North Am. 2023. PMID: 37019767 Review.
The advent of MRI has led to more sporadic vestibular schwannomas diagnosed today than ever before. Despite the average patient being diagnosed in their sixth decade of life with a small tumor and minimal symptoms, population-based data demonstrate that more tumors per cap …
The advent of MRI has led to more sporadic vestibular schwannomas diagnosed today than ever before. Despite the average patient being …
320 results